C12R 2001/91
Cell lines
Official title: Cell lines {; Processes using cell lines}
C12R2001/91 (Cell lines) appears on 101 US grants and 69 published applications in this corpus.
Search patents in C12R- Granted patents
- 101
- Published applications
- 69
- Assignees
- 77
- Inventors
- 267
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 7 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 2 |
| 2002 | 2 | 4 |
| 2003 | 2 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 2 | 3 |
| 2014 | 4 | 6 |
| 2015 | 2 | 2 |
| 2016 | 5 | 6 |
| 2017 | 4 | 3 |
| 2018 | 2 | 5 |
| 2019 | 6 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 2 |
| 2022 | 0 | 2 |
| 2023 | 3 | 2 |
| 2024 | 2 | 7 |
| 2025 | 2 | 8 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells21 Apr 2026US 12,606,803 B2
- Expression cassette containing overlapping open reading frames and application16 Sep 2025US 12,416,019 B2Genevoyager (Wuhan) Co., Ltd.
- Sialyltransferases for the production of sialylated oligosaccharides1 Jul 2025US 12,344,875 B2Inbiose N.V.
- Method for treatment and control of plant disease2 Jul 2024US 12,024,703 B2The Texas A&MUniversity System
- Recombinant viral vector and use thereof13 Aug 2026US 2026/0234663 A1
- Novel capsid protein variant and use thereof6 Aug 2026US 2026/0226111 A1
- Human sebaceous gland carcinoma cell line and us thereof28 May 2026US 2026/0146236 A1Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicin
- Bivalent inactivated ev71-ca16 vaccine, method for preparing the same, and use thereof12 Mar 2026US 2026/0069673 A1Aim Action Biopharm Co., Ltd
- Adeno-associated virus structural plasmid capable of improving adeno-assocaited virus titer26 Feb 2026US 2026/0055427 A1Zhenjiang Probio Biotech Co., Ltd.
Most cited
By later US patents
- Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)104US 4,603,106 AThe Rockefeller University · 1986
- Antibody production from hybrid cell line97US 4,350,683 ANational Research Development Corporation · 1982
- Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)72US 4,822,776 AThe Rockefeller University · 1989
- Vascular permeability factor66US 4,456,550 APresident and Fellows of Harvard College · 1984
- Monoclonal antibodies to cachectin/tumor necrosis factor and methods for preparing same49US 5,698,419 AThe Rockefeller University · 1997